BSRBR data showed that patients on anti-TNF therapy were twice as likely to develop septic arthritis as controls (adjusted hazard ratio [HR] = 2.0, 95% confidence interval [CI] = 1.2-3.7). This evidence concerns the gene TNF and bacterial arthritis.